Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo

Detalhes bibliográficos
Autor(a) principal: Daltio, Claudiane Salles
Data de Publicação: 2011
Outros Autores: Mari, Jair Jesus, Ferraz, Marcos Bosi
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista de Saúde Pública
Texto Completo: https://www.revistas.usp.br/rsp/article/view/32925
Resumo: OBJECTIVE: To assess direct medical costs associated with schizophrenia relapses in mental health services. METHODS: The study was conducted in three health facilities in the city of São Paulo: a public state hospital; a Brazilian National Health System (SUS)-contracted hospital; and a community mental health center. Medical records of 90 patients with schizophrenia who received care in 2006 were reviewed. Information on inpatient expenditures was collected and used for cost estimates. RESULTS: Mean direct medical cost of schizophrenia relapses per patient was US$ 4,083.50 (R$ 8,167.58) in the public state hospital; US$ 2,302.76 (R$ 4,605.46) in the community mental health center; and US$ 1,198.50 (R$ 2,397.74) in the SUS-affiliated hospital. The main component was daily inpatient room rates (87% - 98%). Medication costs varied depending on the use of typical or atypical antipsychotic drugs. Atypical antipsychotic drugs were more often used in the community mental health center. CONCLUSIONS: Costs associated with schizophrenia relapses support investments in antipsychotic drugs and strategies to reduce disease relapse and the need for mental health inpatient services. Treating patients in a community mental health center was associated with medium costs and added the benefit of not depriving these patients from family life.
id USP-23_8d37a42f7e9688fb26aeb57ff0a9568f
oai_identifier_str oai:revistas.usp.br:article/32925
network_acronym_str USP-23
network_name_str Revista de Saúde Pública
repository_id_str
spelling Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo Costo directo médico-hospitalario de recaída en esquizofrenia en servicios de salud en la ciudad de Sao Paulo, sureste de Brasil Custo direto médico-hospitalar de recaída em esquizofrenia em serviços de saúde na cidade de São Paulo Esquizofrenia^i2^seconoRecidivaCustos Diretos de ServiçosCustos de Cuidados de SaúdeServiços de Saúde MentalEsquizofrenia^i3^seconoRecurrenciaCostos Directos de ServiciosCostos de la Atención en SaludServicios de Salud MentalSchizophrenia^i1^seconomRecurrenceDirect Service CostsHealth Care CostsMental Health Services OBJECTIVE: To assess direct medical costs associated with schizophrenia relapses in mental health services. METHODS: The study was conducted in three health facilities in the city of São Paulo: a public state hospital; a Brazilian National Health System (SUS)-contracted hospital; and a community mental health center. Medical records of 90 patients with schizophrenia who received care in 2006 were reviewed. Information on inpatient expenditures was collected and used for cost estimates. RESULTS: Mean direct medical cost of schizophrenia relapses per patient was US$ 4,083.50 (R$ 8,167.58) in the public state hospital; US$ 2,302.76 (R$ 4,605.46) in the community mental health center; and US$ 1,198.50 (R$ 2,397.74) in the SUS-affiliated hospital. The main component was daily inpatient room rates (87% - 98%). Medication costs varied depending on the use of typical or atypical antipsychotic drugs. Atypical antipsychotic drugs were more often used in the community mental health center. CONCLUSIONS: Costs associated with schizophrenia relapses support investments in antipsychotic drugs and strategies to reduce disease relapse and the need for mental health inpatient services. Treating patients in a community mental health center was associated with medium costs and added the benefit of not depriving these patients from family life. OBJETIVO: Evaluar el costo directo médico-hospitalario de la recaída en esquizofrenia, en servicios en salud mental. MÉTODOS: Estudio conducido en tres servicios de salud de la ciudad de Sao Paulo (Sureste de Brasil): un hospital público estatal, un hospital contratado en convenio con el Sistema Único de Salud, y un centro de atención psicosocial. Se analizaron 90 prontuarios de pacientes portadores de esquizofrenia atendidos durante el año de 2006. Los recursos utilizados durante la permanencia de los pacientes en los servicios fueron obtenidos y valorados para cálculos de las estimaciones. RESULTADOS: El costo directo médico-hospitalario promedio de la recaída en esquizofrenia, por paciente, fue de US$ 4,083.50 (R$ 8.167,58) en el hospital público estatal; US$ 2,302.76 (R$ 4.605,46) en el centro de atención psicosocial y de US$ 1,198.50 (R$ 2.397,74) en el hospital con convenio. El principal componente fue el costo por día (87% a 98%). El costo con medicación difirió con relación a la utilización de antipsicóticos típicos o atípicos, siendo mayor en el centro de atención psicosocial, el mayor uso de atípicos. CONCLUSIONES: La inversión en medicamentos antipsióticos y en estrategias que disminuyan la recaída y la necesidad de pagos diarios en los servicios, especialmente hospitalarios, son justificables por la proporción de los costos que estas representan. Tratar la recaída en el centro de atención psicosocial presentó un costo intermedio, con el beneficio de no privar al paciente de la convivencia familiar. OBJETIVO: Avaliar o custo direto médico-hospitalar da recaída em esquizofrenia, em serviços em saúde mental. MÉTODOS: Estudo conduzido em três serviços de saúde da cidade de São Paulo: um hospital público estadual, um hospital contratado conveniado ao Sistema Único de Saúde e um centro de atenção psicossocial. Foram analisados 90 prontuários de pacientes portadores de esquizofrenia atendidos durante o ano de 2006. Os recursos utilizados durante a permanência dos pacientes nos serviços foram obtidos e valorados para cálculos das estimativas. RESULTADOS: O custo direto médico-hospitalar médio da recaída em esquizofrenia, por paciente, foi de R$ 8.167,58 (US$ 4,083.50) no hospital público estadual, R$ 4.605,46 (US$ 2,302.76) no centro de atenção psicossocial e de R$ 2.397,74 (US$ 1,198.50) no hospital conveniado. O principal componente foi o custo com diárias (87% a 98%). O custo com medicação diferiu quanto à utilização de antipsicóticos típicos ou atípicos. O uso de atípicos foi maior no centro de atenção psicossocial. CONCLUSÕES: O investimento em medicações antipsicóticas e em estratégias que diminuam a recaída e a necessidade de diárias nos serviços, especialmente hospitalares, são justificáveis pela proporção dos custos que estas representam. Tratar a recaída no centro de atenção psicossocial apresentou um custo intermediário, com o benefício de não privar o paciente do convívio familiar. Universidade de São Paulo. Faculdade de Saúde Pública2011-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rsp/article/view/3292510.1590/S0034-89102010005000049Revista de Saúde Pública; Vol. 45 No. 1 (2011); 14-23 Revista de Saúde Pública; Vol. 45 Núm. 1 (2011); 14-23 Revista de Saúde Pública; v. 45 n. 1 (2011); 14-23 1518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/rsp/article/view/32925/35496Copyright (c) 2017 Revista de Saúde Públicainfo:eu-repo/semantics/openAccessDaltio, Claudiane SallesMari, Jair JesusFerraz, Marcos Bosi2012-07-11T22:30:52Zoai:revistas.usp.br:article/32925Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2012-07-11T22:30:52Revista de Saúde Pública - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo
Costo directo médico-hospitalario de recaída en esquizofrenia en servicios de salud en la ciudad de Sao Paulo, sureste de Brasil
Custo direto médico-hospitalar de recaída em esquizofrenia em serviços de saúde na cidade de São Paulo
title Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo
spellingShingle Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo
Daltio, Claudiane Salles
Esquizofrenia^i2^secono
Recidiva
Custos Diretos de Serviços
Custos de Cuidados de Saúde
Serviços de Saúde Mental
Esquizofrenia^i3^secono
Recurrencia
Costos Directos de Servicios
Costos de la Atención en Salud
Servicios de Salud Mental
Schizophrenia^i1^seconom
Recurrence
Direct Service Costs
Health Care Costs
Mental Health Services
title_short Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo
title_full Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo
title_fullStr Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo
title_full_unstemmed Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo
title_sort Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo
author Daltio, Claudiane Salles
author_facet Daltio, Claudiane Salles
Mari, Jair Jesus
Ferraz, Marcos Bosi
author_role author
author2 Mari, Jair Jesus
Ferraz, Marcos Bosi
author2_role author
author
dc.contributor.author.fl_str_mv Daltio, Claudiane Salles
Mari, Jair Jesus
Ferraz, Marcos Bosi
dc.subject.por.fl_str_mv Esquizofrenia^i2^secono
Recidiva
Custos Diretos de Serviços
Custos de Cuidados de Saúde
Serviços de Saúde Mental
Esquizofrenia^i3^secono
Recurrencia
Costos Directos de Servicios
Costos de la Atención en Salud
Servicios de Salud Mental
Schizophrenia^i1^seconom
Recurrence
Direct Service Costs
Health Care Costs
Mental Health Services
topic Esquizofrenia^i2^secono
Recidiva
Custos Diretos de Serviços
Custos de Cuidados de Saúde
Serviços de Saúde Mental
Esquizofrenia^i3^secono
Recurrencia
Costos Directos de Servicios
Costos de la Atención en Salud
Servicios de Salud Mental
Schizophrenia^i1^seconom
Recurrence
Direct Service Costs
Health Care Costs
Mental Health Services
description OBJECTIVE: To assess direct medical costs associated with schizophrenia relapses in mental health services. METHODS: The study was conducted in three health facilities in the city of São Paulo: a public state hospital; a Brazilian National Health System (SUS)-contracted hospital; and a community mental health center. Medical records of 90 patients with schizophrenia who received care in 2006 were reviewed. Information on inpatient expenditures was collected and used for cost estimates. RESULTS: Mean direct medical cost of schizophrenia relapses per patient was US$ 4,083.50 (R$ 8,167.58) in the public state hospital; US$ 2,302.76 (R$ 4,605.46) in the community mental health center; and US$ 1,198.50 (R$ 2,397.74) in the SUS-affiliated hospital. The main component was daily inpatient room rates (87% - 98%). Medication costs varied depending on the use of typical or atypical antipsychotic drugs. Atypical antipsychotic drugs were more often used in the community mental health center. CONCLUSIONS: Costs associated with schizophrenia relapses support investments in antipsychotic drugs and strategies to reduce disease relapse and the need for mental health inpatient services. Treating patients in a community mental health center was associated with medium costs and added the benefit of not depriving these patients from family life.
publishDate 2011
dc.date.none.fl_str_mv 2011-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rsp/article/view/32925
10.1590/S0034-89102010005000049
url https://www.revistas.usp.br/rsp/article/view/32925
identifier_str_mv 10.1590/S0034-89102010005000049
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rsp/article/view/32925/35496
dc.rights.driver.fl_str_mv Copyright (c) 2017 Revista de Saúde Pública
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2017 Revista de Saúde Pública
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
dc.source.none.fl_str_mv Revista de Saúde Pública; Vol. 45 No. 1 (2011); 14-23
Revista de Saúde Pública; Vol. 45 Núm. 1 (2011); 14-23
Revista de Saúde Pública; v. 45 n. 1 (2011); 14-23
1518-8787
0034-8910
reponame:Revista de Saúde Pública
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Revista de Saúde Pública
collection Revista de Saúde Pública
repository.name.fl_str_mv Revista de Saúde Pública - Universidade de São Paulo (USP)
repository.mail.fl_str_mv revsp@org.usp.br||revsp1@usp.br
_version_ 1800221791719784448

Registros relacionados